Honda: Toni Bou Wins 15th Consecutive FIM Trial World Championship Title

TOKYO, Sep 20, 2021 – (JCN Newswire via SEAPRWire.com) – HRC (Honda Racing Corporation) contract rider and Honda factory team(1) (Repsol Honda Team) rider Toni Bou has won the 2021 FIM(2) Trial World Championship. He has clinched his 15th consecutive title by winning the final round in Portugal, held on September 18. Toni Bou (Portuguese […]

ClinTex (CTi) Launches CTi-OEM Blockchain Clinical Trial App

LONDON, Aug 3, 2021 – (ACN Newswire via SEAPRWire.com) – The ClinTex (CTi) tokenized platform (clintex.io) will be the first of its kind to utilize blockchain-based clinical data analytics to address the main causes of clinical trial inefficiency, helping to drive down the cost of new medicines and expediting their delivery to patients. ClinTex (CTi) […]

Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities

ADELAIDE, AUS, Jun 4, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital 2021. Results from the survey […]

Avance Clinical Releases Industry Survey Results at BIO Korea 2021

ADELAIDE, AUS, May 27, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a recent industry survey conducted by the company that found data quality to be the most important criteria for selecting a CRO for […]

Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials

ADELAIDE, AUS, May 21, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Endpoints News to share the latest on deconvoluting inflammation and immunology for clinical trials, in a webinar hosted by Endpoints News Editor Arsalan Arif. Agilex Biolabs’ Director, […]

Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand

ADELAIDE, AUS, May 7, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. Avance Clinical is accredited as […]

Agilex Biolabs Congratulates Bionomics Limited on BNC210 PK Results

ADELAIDE, AUS, Apr 30, 2021 – (ACN Newswire via SEAPRWire.com) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today congratulated client Bionomics Limited (Bionomics) on its positive pharmacokinetic (PK) results from a 7-day dosing study in healthy volunteers using the newly developed solid dose oral tablet formulation of […]

Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health Sciences Connect

ADELAIDE, AU, Apr 22, 2021 – (ACN Newswire via SEAPRWire.com) – The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. Title: Decentralized Trials – No Going BackLink: […]

Eisai: 18-Month, Pre-Specified Analysis Showing Consistent Reduction in Clinical Outcome Measures from a Lecanemab (BAN2401) Phase 2b Clinical Trial in Early Alzheimer’s Disease

TOKYO, Apr 20, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. today announced the publication of an article, A Randomized, Double-Blind Phase 2b Proof of Concept Clinical Trial in Early Alzheimer’s Disease with Lecanemab, an Anti-Abeta Protofibril Antibody, in the peer-reviewed journal Alzheimer’s Research and Therapy. The manuscript describes results […]

TOT BIOPHARM Announces A Number of Key Anti-Tumor Drugs Have Entered the Pivotal Clinical Stage in 2020

HONG KONG, Mar 24, 2021 – (ACN Newswire via SEAPRWire.com) – TOT BIOPHARM International Company Limited (“TOT BIOPHARM” or the “Company”; stock code: 1875.HK), a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies, announced today its audited annual results for the year ended 31 December 2020. Milestones of 2020 Annual […]

Agilex Biolabs Showcases Advanced Immunoassay and Immunobiology Services at Bio-Europe Spring 2021

ADELAIDE, AU, Mar 17, 2021 – (ACN Newswire) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced it will showcase its world-class immunoassay and immunobiology services for regulated bioanalysis at Bio-Europe 2021.Dr Kurt J. Sales Agilex Biolabs’ Director Immunoassay said:“Our experienced team can develop or transfer a method for any biologic […]

Fujitsu Embarks on Joint Research with National Cancer Center Japan to Create New Services for Drug Development and Clinical Trials

TOKYO, Mar 18, 2021 – (JCN Newswire via SEAPRWire.com) – Fujitsu today announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japan. The joint research will center on exploring ways that real-world data(1), including medical information from electronic records, can be leveraged to contribute to the development of new drugs, clinical […]

Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones

ADELAIDE, AU, Feb 26, 2021 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts. The two organizations have been working together to deliver world-class clinical research […]

China Biotech Services LY007 Cell Injection Obtained Clinical Trial Approval Letter

HONG KONG, Jan 28, 2021 – (ACN Newswire) – China Biotech Services Holdings Limited (“CH BIOTECH SER” or “Company”, stock code: 8037.HK) non-wholly-owned subsidiary Shanghai Longyao Biotechnology Co., Ltd. ( “Shanghai Longyao”) received an approval letter from the National Medical Products Administration for a clinical trial of the Company’s LY007 Cellular Injection on January 21, […]

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SN1011 in China

HONG KONG, Jan 18, 2021 – (ACN Newswire) – SinoMab BioScience Limited (“SinoMab” or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the first healthy subject was successfully dosed in the Phase […]

Avance Clinical Wins MasterControl 2020 Innovation Excellence Award

ADELAIDE, AU, Oct 30, 2020 – (ACN Newswire) – The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical today accepted the MasterControl 2020 Innovation Excellence Award in a virtual ceremony. L-R: Priyanka Chamoli, Director Quality Assurance, Emma Woolman, Senior Compliance and Training Officer, Yvonne Lungershausen, […]

Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Program

ADELAIDE, AU, Oct 30, 2020 – (ACN Newswire) – Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, congratulates client company Shasqi on the announcement of the first-ever application of click chemistry in humans, with the launch of the Company’s lead clinical candidate, SQ3370. Shasqi is the first Y Combinator-backed biotech company […]

Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma – announced at Bio-Europe 2020

BIO-Europe, Munich, Oct 28, 2020 – (ACN Newswire) – Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable clinical solution for biotechs. The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand […]

Endpoints News Presents “Why Australia and Agilex Biolabs for your Next Clinical Trial” for Bio Europe 2020

ADELAIDE, AU, Oct 27, 2020 – (ACN Newswire) – Agilex Biolabs, Australia’s most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, has partnered with Endpoints News to produce an exceptional step-by-step webinar on how to run your trial in Australia, and why Agilex Biolabs is the leading biolabs partner. Watch here (no charge) https://tinyurl.com/yyzf6o44 Agilex […]